Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E POULSEN

Showing results (311-320 of 363) with videos related to

Pageof 37
Sort By:
The Open Cardiovascular Medicine Journal|December 18, 2009
Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006H Dominguez, T K Schramm, M L Norgaard, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patientsMorten Petersen, Jon T Andersen, Brian R Hjelvang, et al.
Pharmacogenetics and Genomics|July 5, 2012
Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trialMorten Petersen, Jon T Andersen, Espen Jimenez-Solem, et al.
Mutation Research|September 29, 2004
Sucrose and IQ induced mutations in rat colon by independent mechanismMax Hansen, Mikkel Thomas Hald, Herman Autrup, et al.
Resuscitation|November 10, 2011
Hospital admissions and pharmacotherapy before out-of-hospital cardiac arrest according to agePeter Weeke, Fredrik Folke, Gunnar H Gislason, et al.
Free Radical Biology & Medicine|March 1, 2011
Genetic and environmental influences on oxidative damage assessed in elderly Danish twinsKasper Broedbaek, Rasmus Ribel-Madsen, Trine Henriksen, et al.
Clinical and Experimental Pharmacology & Physiology|June 19, 2012
Effect of the Arg389Gly β₁-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatmentMorten Petersen, Jon T Andersen, Espen Jimenez-Solem, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 28, 2003
The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivoH Verhagen, O I Aruoma, J H M van Delft, et al.
Diabetes, Obesity & Metabolism|June 17, 2020
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trialNicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Pageof 37

Showing results (311-320 of 363) with videos related to

Sort By:
Pageof 37
The Open Cardiovascular Medicine Journal|December 18, 2009
Initiation and persistence to statin treatment in patients with diabetes receiving glucose-lowering medications 1997- 2006H Dominguez, T K Schramm, M L Norgaard, et al.
British Journal of Clinical Pharmacology|March 15, 2011
Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patientsMorten Petersen, Jon T Andersen, Brian R Hjelvang, et al.
Pharmacogenetics and Genomics|July 5, 2012
Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trialMorten Petersen, Jon T Andersen, Espen Jimenez-Solem, et al.
Mutation Research|September 29, 2004
Sucrose and IQ induced mutations in rat colon by independent mechanismMax Hansen, Mikkel Thomas Hald, Herman Autrup, et al.
Resuscitation|November 10, 2011
Hospital admissions and pharmacotherapy before out-of-hospital cardiac arrest according to agePeter Weeke, Fredrik Folke, Gunnar H Gislason, et al.
Free Radical Biology & Medicine|March 1, 2011
Genetic and environmental influences on oxidative damage assessed in elderly Danish twinsKasper Broedbaek, Rasmus Ribel-Madsen, Trine Henriksen, et al.
Clinical and Experimental Pharmacology & Physiology|June 19, 2012
Effect of the Arg389Gly β₁-adrenoceptor polymorphism on plasma renin activity and heart rate, and the genotype-dependent response to metoprolol treatmentMorten Petersen, Jon T Andersen, Espen Jimenez-Solem, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|March 28, 2003
The 10 basic requirements for a scientific paper reporting antioxidant, antimutagenic or anticarcinogenic potential of test substances in in vitro experiments and animal studies in vivoH Verhagen, O I Aruoma, J H M van Delft, et al.
Diabetes, Obesity & Metabolism|June 17, 2020
Effect of short-acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double-blind placebo-controlled trialNicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Free Radical Research|May 12, 2023
Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trialsEmil List Larsen, Andreas Andersen, Laura K Kjær, et al.
Pageof 37